Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0XU0G
|
||||
| Former ID |
DNC009663
|
||||
| Drug Name |
N-(quinolin-3-yl)-6-(sulfamoylamino)hexanamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529866] | ||
| Formula |
C15H20N4O3S
|
||||
| Canonical SMILES |
C1=CC=C2C(=C1)C=C(C=N2)NC(=O)CCCCCNS(=O)(=O)N
|
||||
| InChI |
1S/C15H20N4O3S/c16-23(21,22)18-9-5-1-2-8-15(20)19-13-10-12-6-3-4-7-14(12)17-11-13/h3-4,6-7,10-11,18H,1-2,5,8-9H2,(H,19,20)(H2,16,21,22)
|
||||
| InChIKey |
HIRQWWZRMZTUFZ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histone deacetylase 6 | Target Info | Inhibitor | [529866] | |
| KEGG Pathway | Alcoholism | ||||
| Viral carcinogenesis | |||||
| Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
| Signaling events mediated by HDAC Class I | |||||
| References | |||||